AUSTAR LIFESCIENCE LIMITEDAUSTAR LIFESCIENCE LIMITEDAUSTAR LIFESCIENCE LIMITED

AUSTAR LIFESCIENCE LIMITED

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪333.18 M‬HKD
−0.14HKD
‪−125.39 M‬HKD
‪1.95 B‬HKD
‪135.63 M‬
Beta (1Y)
0.40
Employees (FY)
‪1.61 K‬
Change (1Y)
−303 −15.84%
Revenue / Employee (1Y)
‪154.98 K‬HKD
Net income / Employee (1Y)
‪−2.87 K‬HKD

About AUSTAR LIFESCIENCE LIMITED


CEO
Kwok Keung Ho
Headquarters
Shanghai
Founded
2014
FIGI
BBG007FFXJB4
Austar Lifesciences Ltd. is an investment holding company, which engages in the provision of engineering solutions to pharmaceutical manufacturers and research institutes. It operates through the following segments: Liquid and Bioprocess System, Clean Room and Automation Control and Monitoring System, Powder and Solid System, Good Manufacturing Practice (GMP) Compliance Service, Life Science Consumables, and Distribution and Agency of Pharmaceutical Equipment. The Liquid and Bioprocess System segment provides solutions in pharmaceutical and water systems to treat water. The Clean Room and Automation Control and Monitoring System segment consists of a solution to set up a clean room environment with controlled level of contamination; and automation control and monitoring systems. The Powder and Solid System segment includes solutions to set up systems in handling pharmaceutical products. The GMP Compliance Service segment offers consultancy services. The Life Science Consumables segment distributes life science consumables including cleansers, disinfectants, indicators, sterile bags, cleaning tools, and personal protection items. The Distribution and Agency of Pharmaceutical Equipment segment engages in the distribution and sale of pharmaceutical equipment, parts and components. The company was founded by Ho Kwok Keung on January 9, 2014 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 6118 is 0.64 HKD — it has decreased by −4.62% in the past 24 hours. Watch AUSTAR LIFESCIENCE LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange AUSTAR LIFESCIENCE LIMITED stocks are traded under the ticker 6118.
6118 stock has fallen by −1.59% compared to the previous week, the month change is a −17.33% fall, over the last year AUSTAR LIFESCIENCE LIMITED has showed a −67.68% decrease.
6118 reached its all-time high on Oct 18, 2021 with the price of 30.90 HKD, and its all-time low was 0.47 HKD and was reached on Sep 20, 2024. View more price dynamics on 6118 chart.
See other stocks reaching their highest and lowest prices.
6118 stock is 8.33% volatile and has beta coefficient of 0.40. Track AUSTAR LIFESCIENCE LIMITED stock price on the chart and check out the list of the most volatile stocks — is AUSTAR LIFESCIENCE LIMITED there?
Today AUSTAR LIFESCIENCE LIMITED has the market capitalization of ‪333.18 M‬, it has increased by 3.17% over the last week.
Yes, you can track AUSTAR LIFESCIENCE LIMITED financials in yearly and quarterly reports right on TradingView.
AUSTAR LIFESCIENCE LIMITED is going to release the next earnings report on Apr 1, 2025. Keep track of upcoming events with our Earnings Calendar.
6118 net income for the last half-year is ‪6.37 M‬ HKD, while the previous report showed ‪−79.44 M‬ HKD of net income which accounts for 108.02% change. Track more AUSTAR LIFESCIENCE LIMITED financial stats to get the full picture.
No, 6118 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 22, 2024, the company has ‪1.61 K‬ employees. See our rating of the largest employees — is AUSTAR LIFESCIENCE LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AUSTAR LIFESCIENCE LIMITED EBITDA is ‪90.62 M‬ HKD, and current EBITDA margin is −0.37%. See more stats in AUSTAR LIFESCIENCE LIMITED financial statements.
Like other stocks, 6118 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AUSTAR LIFESCIENCE LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AUSTAR LIFESCIENCE LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AUSTAR LIFESCIENCE LIMITED stock shows the sell signal. See more of AUSTAR LIFESCIENCE LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.